APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Bioconjugation

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Bioconjugation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 173898320326 December 2025190 pages

Choose your research edition.

Industry ResearchBioconjugation Industry Research Report 2026137 pages · $2,950 USDIndustry Growth & TrendsGlobal Bioconjugation Industry Growth and Trends Forecast to 2032119 pages · $3,450 USDMarket StructureGlobal Bioconjugation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Bioconjugation Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Bioconjugation Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Bioconjugation market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Bioconjugation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Bioconjugation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Bioconjugation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Bioconjugation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Bioconjugation include WuXi Biologics, Thermo Fisher Scientific, Merck, Roche, Lonza, AbbVie, Sartorius, Promega and Piramal Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Bioconjugation market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Bioconjugation and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Bioconjugation sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Bioconjugation market size, projected growth trends, production technologies, key applications, and end-use industries.

Bioconjugation Segment by Company

WuXi Biologics

Thermo Fisher Scientific

Merck

Roche

Lonza

AbbVie

Sartorius

Promega

Piramal Pharma

Genscript Biotech

Danaher

Charles River Laboratories

Catalent

Bio-Rad Laboratories

BD

Agilent

Bioconjugation Segment by Type

Chemical Conjugation

Click Chemistry

Enzyme-mediated Conjugatio

Others

Bioconjugation Segment by Application

Pharmaceutical

Hosptial

Research Institutes

Others

Bioconjugation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Bioconjugation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Bioconjugation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Bioconjugation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Bioconjugation market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Bioconjugation manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Bioconjugation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Bioconjugation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Bioconjugation Industry Trends Table 2. Bioconjugation Industry Drivers Table 3. Bioconjugation Industry Opportunities and Challenges Table 4. Bioconjugation Industry Restraints Table 5. Global Bioconjugation Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Bioconjugation Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Bioconjugation Sales by Manufacturers (Units) & (2021-2026) Table 8. Global Bioconjugation Sales Market Share by Manufacturers Table 9. Global Bioconjugation Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Bioconjugation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Bioconjugation Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Bioconjugation Manufacturers, Product Type & Application Table 13. Global Bioconjugation Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Bioconjugation by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Chemical Conjugation Table 17. Major Manufacturers of Click Chemistry Table 18. Major Manufacturers of Enzyme-mediated Conjugatio Table 19. Major Manufacturers of Others Table 20. Global Bioconjugation Sales by Type 2021 VS 2025 VS 2032 (Units) Table 21. Global Bioconjugation Sales by Type (2021-2026) & (Units) Table 22. Global Bioconjugation Sales by Type (2027-2032) & (Units) Table 23. Global Bioconjugation Sales Market Share by Type (2021-2026) Table 24. Global Bioconjugation Sales Market Share by Type (2027-2032) Table 25. Global Bioconjugation Revenue by Type 2021 VS 2025 VS 2032 (Units) Table 26. Global Bioconjugation Revenue by Type (2021-2026) & (Units) Table 27. Global Bioconjugation Revenue by Type (2027-2032) & (Units) Table 28. Global Bioconjugation Revenue Market Share by Type (2021-2026) Table 29. Global Bioconjugation Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Pharmaceutical Table 31. Major Manufacturers of Hosptial Table 32. Major Manufacturers of Research Institutes Table 33. Major Manufacturers of Others Table 34. Global Bioconjugation Sales by Application 2021 VS 2025 VS 2032 (Units) Table 35. Global Bioconjugation Sales by Application (2021-2026) & (Units) Table 36. Global Bioconjugation Sales by Application (2027-2032) & (Units) Table 37. Global Bioconjugation Sales Market Share by Application (2021-2026) Table 38. Global Bioconjugation Sales Market Share by Application (2027-2032) Table 39. Global Bioconjugation Revenue by Application 2021 VS 2025 VS 2032 (Units) Table 40. Global Bioconjugation Revenue by Application (2021-2026) & (Units) Table 41. Global Bioconjugation Revenue by Application (2027-2032) & (Units) Table 42. Global Bioconjugation Revenue Market Share by Application (2021-2026) Table 43. Global Bioconjugation Revenue Market Share by Application (2027-2032) Table 44. Global Bioconjugation Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 45. Global Bioconjugation Sales by Region (2021-2026) & (Units) Table 46. Global Bioconjugation Sales Market Share by Region (2021-2026) Table 47. Global Bioconjugation Sales Forecasted by Region (2027-2032) & (Units) Table 48. Global Bioconjugation Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Bioconjugation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 50. North America Bioconjugation Sales by Country (2021-2026) & (Units) Table 51. North America Bioconjugation Sales by Country (2027-2032) & (Units) Table 52. Europe Bioconjugation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 53. Europe Bioconjugation Sales by Country (2021-2026) & (Units) Table 54. Europe Bioconjugation Sales by Country (2027-2032) & (Units) Table 55. Asia Pacific Bioconjugation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 56. Asia Pacific Bioconjugation Sales by Country (2021-2026) & (Units) Table 57. Asia Pacific Bioconjugation Sales by Country (2027-2032) & (Units) Table 58. South America, Middle East and Africa Bioconjugation Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (Units) Table 59. South America, Middle East and Africa Bioconjugation Sales by Country (2021-2026) & (Units) Table 60. South America, Middle East and Africa Bioconjugation Sales by Country (2027-2032) & (Units) Table 61. Global Bioconjugation Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Bioconjugation Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Bioconjugation Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Bioconjugation Revenue Market Share by Region (2021-2026) Table 65. Global Bioconjugation Revenue Market Share by Region (2027-2032) Table 66. WuXi Biologics Company Information Table 67. WuXi Biologics Business Overview Table 68. WuXi Biologics Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. WuXi Biologics Bioconjugation Product Portfolio Table 70. WuXi Biologics Recent Development Table 71. Thermo Fisher Scientific Company Information Table 72. Thermo Fisher Scientific Business Overview Table 73. Thermo Fisher Scientific Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Thermo Fisher Scientific Bioconjugation Product Portfolio Table 75. Thermo Fisher Scientific Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Merck Bioconjugation Product Portfolio Table 80. Merck Recent Development Table 81. Roche Company Information Table 82. Roche Business Overview Table 83. Roche Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Roche Bioconjugation Product Portfolio Table 85. Roche Recent Development Table 86. Lonza Company Information Table 87. Lonza Business Overview Table 88. Lonza Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Lonza Bioconjugation Product Portfolio Table 90. Lonza Recent Development Table 91. AbbVie Company Information Table 92. AbbVie Business Overview Table 93. AbbVie Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. AbbVie Bioconjugation Product Portfolio Table 95. AbbVie Recent Development Table 96. Sartorius Company Information Table 97. Sartorius Business Overview Table 98. Sartorius Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Sartorius Bioconjugation Product Portfolio Table 100. Sartorius Recent Development Table 101. Promega Company Information Table 102. Promega Business Overview Table 103. Promega Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Promega Bioconjugation Product Portfolio Table 105. Promega Recent Development Table 106. Piramal Pharma Company Information Table 107. Piramal Pharma Business Overview Table 108. Piramal Pharma Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Piramal Pharma Bioconjugation Product Portfolio Table 110. Piramal Pharma Recent Development Table 111. Genscript Biotech Company Information Table 112. Genscript Biotech Business Overview Table 113. Genscript Biotech Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 114. Genscript Biotech Bioconjugation Product Portfolio Table 115. Genscript Biotech Recent Development Table 116. Danaher Company Information Table 117. Danaher Business Overview Table 118. Danaher Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 119. Danaher Bioconjugation Product Portfolio Table 120. Danaher Recent Development Table 121. Charles River Laboratories Company Information Table 122. Charles River Laboratories Business Overview Table 123. Charles River Laboratories Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 124. Charles River Laboratories Bioconjugation Product Portfolio Table 125. Charles River Laboratories Recent Development Table 126. Catalent Company Information Table 127. Catalent Business Overview Table 128. Catalent Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 129. Catalent Bioconjugation Product Portfolio Table 130. Catalent Recent Development Table 131. Bio-Rad Laboratories Company Information Table 132. Bio-Rad Laboratories Business Overview Table 133. Bio-Rad Laboratories Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 134. Bio-Rad Laboratories Bioconjugation Product Portfolio Table 135. Bio-Rad Laboratories Recent Development Table 136. BD Company Information Table 137. BD Business Overview Table 138. BD Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 139. BD Bioconjugation Product Portfolio Table 140. BD Recent Development Table 141. Agilent Company Information Table 142. Agilent Business Overview Table 143. Agilent Bioconjugation Sales (Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 144. Agilent Bioconjugation Product Portfolio Table 145. Agilent Recent Development Table 146. Key Raw Materials Table 147. Raw Materials Key Suppliers Table 148. Bioconjugation Distributors List Table 149. Bioconjugation Customers List Table 150. Research Programs/Design for This Report Table 151. Authors List of This Report Table 152. Secondary Sources Table 153. Primary Sources List of Figures Figure 1. Bioconjugation Product Image Figure 2. Global Bioconjugation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Bioconjugation Market Size (2021-2032) & (US$ Million) Figure 4. Global Bioconjugation Sales (2021-2032) & (Units) Figure 5. Global Bioconjugation Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Bioconjugation Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Chemical Conjugation Image Figure 9. Click Chemistry Image Figure 10. Enzyme-mediated Conjugatio Image Figure 11. Others Image Figure 12. Global Bioconjugation Sales by Type (2021 VS 2025 VS 2032) & (Units) Figure 13. Global Bioconjugation Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Bioconjugation Sales Market Share by Type (2021-2032) Figure 15. Global Bioconjugation Revenue by Type (2021 VS 2025 VS 2032) & (Units) Figure 16. Global Bioconjugation Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Bioconjugation Revenue Market Share by Type (2021-2032) Figure 18. Pharmaceutical Image Figure 19. Hosptial Image Figure 20. Research Institutes Image Figure 21. Others Image Figure 22. Global Bioconjugation Sales by Application (2021 VS 2025 VS 2032) & (Units) Figure 23. Global Bioconjugation Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Bioconjugation Sales Market Share by Application (2021-2032) Figure 25. Global Bioconjugation Revenue by Application (2021 VS 2025 VS 2032) & (Units) Figure 26. Global Bioconjugation Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Bioconjugation Revenue Market Share by Application (2021-2032) Figure 28. North America Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 29. North America Bioconjugation Sales Market Share by Country (2021-2032) Figure 30. U.S. Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 31. Canada Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 32. Mexico Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 33. Europe Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 34. Europe Bioconjugation Sales Market Share by Country (2021-2032) Figure 35. Germany Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 36. France Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 37. U.K. Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 38. Italy Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 39. Netherlands Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 40. Asia Pacific Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 41. Asia Pacific Bioconjugation Sales Market Share by Country (2021-2032) Figure 42. China Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 43. Japan Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 44. South Korea Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 45. Southeast Asia Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 46. India Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 47. Australia Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 48. South America, Middle East and Africa Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 49. South America, Middle East and Africa Bioconjugation Sales Market Share by Country (2021-2032) Figure 50. Brazil Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 51. South Africa Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 52. Saudi Arabia Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 53. Turkey Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 54. Argentina Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 55. UAE Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 56. Egypt Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 57. Chile Bioconjugation Sales and Growth Rate (2021-2032) & (Units) Figure 58. Global Bioconjugation Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Bioconjugation Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Bioconjugation Revenue (2021-2032) & (US$ Million) Figure 61. North America Bioconjugation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Bioconjugation Revenue (2021-2032) & (US$ Million) Figure 63. Europe Bioconjugation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Bioconjugation Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Bioconjugation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Bioconjugation Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Bioconjugation Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Bioconjugation Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Bioconjugation Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Chemical Conjugation
  • Click Chemistry
  • Enzyme-mediated Conjugatio
  • Others
Applications
  • Pharmaceutical
  • Hosptial
  • Research Institutes
  • Others
Companies covered
  • WuXi Biologics
  • Thermo Fisher Scientific
  • Merck
  • Roche
  • Lonza
  • AbbVie
  • Sartorius
  • Promega
  • Piramal Pharma
  • Genscript Biotech
  • Danaher
  • Charles River Laboratories
  • Catalent
  • Bio-Rad Laboratories
  • BD
  • Agilent

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Bioconjugation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Bioconjugation Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Bioconjugation Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Bioconjugation Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Bioconjugation Market Dynamics
  1. 2.1 Bioconjugation Industry Trends
  2. 2.2 Bioconjugation Industry Drivers
  3. 2.3 Bioconjugation Industry Opportunities and Challenges
  4. 2.4 Bioconjugation Industry Restraints
3 Bioconjugation Market by Manufacturers
  1. 3.1 Global Bioconjugation Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Bioconjugation Sales by Manufacturers (2021-2026)
  3. 3.3 Global Bioconjugation Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Bioconjugation Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Bioconjugation Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Bioconjugation Manufacturers, Product Type & Application
  7. 3.7 Global Bioconjugation Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Bioconjugation Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Bioconjugation Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Bioconjugation Tier 1, Tier 2, and Tier 3
4 Bioconjugation Market by Type
  1. 4.1 Bioconjugation Type Introduction
  2. 4.1.1 Chemical Conjugation
  3. 4.1.2 Click Chemistry
  4. 4.1.3 Enzyme-mediated Conjugatio
  5. 4.1.4 Others
  6. 4.2 Global Bioconjugation Sales by Type
  7. 4.2.1 Global Bioconjugation Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Bioconjugation Sales by Type (2021-2032)
  9. 4.2.3 Global Bioconjugation Sales Market Share by Type (2021-2032)
  10. 4.3 Global Bioconjugation Revenue by Type
  11. 4.3.1 Global Bioconjugation Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Bioconjugation Revenue by Type (2021-2032)
  13. 4.3.3 Global Bioconjugation Revenue Market Share by Type (2021-2032)
5 Bioconjugation Market by Application
  1. 5.1 Bioconjugation Application Introduction
  2. 5.1.1 Pharmaceutical
  3. 5.1.2 Hosptial
  4. 5.1.3 Research Institutes
  5. 5.1.4 Others
  6. 5.2 Global Bioconjugation Sales by Application
  7. 5.2.1 Global Bioconjugation Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Bioconjugation Sales by Application (2021-2032)
  9. 5.2.3 Global Bioconjugation Sales Market Share by Application (2021-2032)
  10. 5.3 Global Bioconjugation Revenue by Application
  11. 5.3.1 Global Bioconjugation Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Bioconjugation Revenue by Application (2021-2032)
  13. 5.3.3 Global Bioconjugation Revenue Market Share by Application (2021-2032)
6 Global Bioconjugation Sales by Region
  1. 6.1 Global Bioconjugation Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Bioconjugation Sales by Region (2021-2032)
  3. 6.2.1 Global Bioconjugation Sales by Region (2021-2026)
  4. 6.2.2 Global Bioconjugation Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Bioconjugation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Bioconjugation Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Bioconjugation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Bioconjugation Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Bioconjugation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Bioconjugation Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Bioconjugation Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Bioconjugation Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Bioconjugation Revenue by Region
  1. 7.1 Global Bioconjugation Revenue by Region
  2. 7.1.1 Global Bioconjugation Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Bioconjugation Revenue by Region (2021-2026)
  4. 7.1.3 Global Bioconjugation Revenue by Region (2027-2032)
  5. 7.1.4 Global Bioconjugation Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Bioconjugation Revenue (2021-2032)
  8. 7.2.2 North America Bioconjugation Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Bioconjugation Revenue (2021-2032)
  11. 7.3.2 Europe Bioconjugation Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Bioconjugation Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Bioconjugation Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Bioconjugation Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Bioconjugation Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 WuXi Biologics
  2. 8.1.1 WuXi Biologics Company Information
  3. 8.1.2 WuXi Biologics Business Overview
  4. 8.1.3 WuXi Biologics Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 WuXi Biologics Bioconjugation Product Portfolio
  6. 8.1.5 WuXi Biologics Recent Developments
  7. 8.2 Thermo Fisher Scientific
  8. 8.2.1 Thermo Fisher Scientific Company Information
  9. 8.2.2 Thermo Fisher Scientific Business Overview
  10. 8.2.3 Thermo Fisher Scientific Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Scientific Bioconjugation Product Portfolio
  12. 8.2.5 Thermo Fisher Scientific Recent Developments
  13. 8.3 Merck
  14. 8.3.1 Merck Company Information
  15. 8.3.2 Merck Business Overview
  16. 8.3.3 Merck Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Merck Bioconjugation Product Portfolio
  18. 8.3.5 Merck Recent Developments
  19. 8.4 Roche
  20. 8.4.1 Roche Company Information
  21. 8.4.2 Roche Business Overview
  22. 8.4.3 Roche Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Roche Bioconjugation Product Portfolio
  24. 8.4.5 Roche Recent Developments
  25. 8.5 Lonza
  26. 8.5.1 Lonza Company Information
  27. 8.5.2 Lonza Business Overview
  28. 8.5.3 Lonza Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Lonza Bioconjugation Product Portfolio
  30. 8.5.5 Lonza Recent Developments
  31. 8.6 AbbVie
  32. 8.6.1 AbbVie Company Information
  33. 8.6.2 AbbVie Business Overview
  34. 8.6.3 AbbVie Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 AbbVie Bioconjugation Product Portfolio
  36. 8.6.5 AbbVie Recent Developments
  37. 8.7 Sartorius
  38. 8.7.1 Sartorius Company Information
  39. 8.7.2 Sartorius Business Overview
  40. 8.7.3 Sartorius Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Sartorius Bioconjugation Product Portfolio
  42. 8.7.5 Sartorius Recent Developments
  43. 8.8 Promega
  44. 8.8.1 Promega Company Information
  45. 8.8.2 Promega Business Overview
  46. 8.8.3 Promega Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Promega Bioconjugation Product Portfolio
  48. 8.8.5 Promega Recent Developments
  49. 8.9 Piramal Pharma
  50. 8.9.1 Piramal Pharma Company Information
  51. 8.9.2 Piramal Pharma Business Overview
  52. 8.9.3 Piramal Pharma Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Piramal Pharma Bioconjugation Product Portfolio
  54. 8.9.5 Piramal Pharma Recent Developments
  55. 8.10 Genscript Biotech
  56. 8.10.1 Genscript Biotech Company Information
  57. 8.10.2 Genscript Biotech Business Overview
  58. 8.10.3 Genscript Biotech Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Genscript Biotech Bioconjugation Product Portfolio
  60. 8.10.5 Genscript Biotech Recent Developments
  61. 8.11 Danaher
  62. 8.11.1 Danaher Company Information
  63. 8.11.2 Danaher Business Overview
  64. 8.11.3 Danaher Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Danaher Bioconjugation Product Portfolio
  66. 8.11.5 Danaher Recent Developments
  67. 8.12 Charles River Laboratories
  68. 8.12.1 Charles River Laboratories Company Information
  69. 8.12.2 Charles River Laboratories Business Overview
  70. 8.12.3 Charles River Laboratories Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Charles River Laboratories Bioconjugation Product Portfolio
  72. 8.12.5 Charles River Laboratories Recent Developments
  73. 8.13 Catalent
  74. 8.13.1 Catalent Company Information
  75. 8.13.2 Catalent Business Overview
  76. 8.13.3 Catalent Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Catalent Bioconjugation Product Portfolio
  78. 8.13.5 Catalent Recent Developments
  79. 8.14 Bio-Rad Laboratories
  80. 8.14.1 Bio-Rad Laboratories Company Information
  81. 8.14.2 Bio-Rad Laboratories Business Overview
  82. 8.14.3 Bio-Rad Laboratories Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Bio-Rad Laboratories Bioconjugation Product Portfolio
  84. 8.14.5 Bio-Rad Laboratories Recent Developments
  85. 8.15 BD
  86. 8.15.1 BD Company Information
  87. 8.15.2 BD Business Overview
  88. 8.15.3 BD Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BD Bioconjugation Product Portfolio
  90. 8.15.5 BD Recent Developments
  91. 8.16 Agilent
  92. 8.16.1 Agilent Company Information
  93. 8.16.2 Agilent Business Overview
  94. 8.16.3 Agilent Bioconjugation Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Agilent Bioconjugation Product Portfolio
  96. 8.16.5 Agilent Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Bioconjugation Value Chain Analysis
  2. 9.1.1 Bioconjugation Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Bioconjugation Production Mode & Process
  6. 9.2 Bioconjugation Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Bioconjugation Distributors
  9. 9.2.3 Bioconjugation Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst